ZL-1222

N/A

Report date: 2025/04/29 17:12:57

Base Information

Drug NameZL-1222
Drug Alias NameZL-1222
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionAnti-PD-1Interleukin-12 modulators
TargetsProgrammed cell death protein 1Interleukin-12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZai Lab Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZai Lab Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A